ADD ANYTHING HERE OR JUST REMOVE IT…
Wrong menu selected
Acarix Acarix
  • Product

    Background

    • What is Coronary Artery Disease (CAD)?
    • Diagnosing CAD

    About the product

    • The CADScor® System
    • How does it work
  • Resources

    Testimonials

    • HCP stories
    • Patient stories

    References

    • Clinical Studies
    • Questionnaire
    • Downloads (US)
    • Downloads (EU)
    • Education

    Support

    • Training
    • FAQ
    • Reimbursement

    Physician Locator

    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Rights Issue/Warrant Program
    • Previous Rights Issue
    • Investor Presentations
  • Company

    Who we are

    • About Acarix
    • leadership
    • Join the team

    Get in touch

    • Contact us
    • Investigator Initiated Study
  • News
    • Press
    • Events
    • Social Media
Account
Search
Book a Demo
Acarix Acarix
Book a demo
Menu
author-avatar acarix
Corporate Action, English, IR, Issuance, Listing Regulation, News, Regulatory, Shares
November 18, 2024
09 Oct 2019

The subscription period in Acarix’ rights issue commence today

Press releaseMalmö, 9 October 2019The subscription period in Acarix' rights issue commence todayThe board of directors of Acarix A...
Continue reading
author-avatar acarix
Corporate Action, English, IR, Listing Regulation, News, Prospectus, Regulatory
November 18, 2024
30 Sep 2019

Acarix publish EU growth prospectus in connection with rights issue of up to approximately SEK 51.8 million

Press releaseMalmö, 30 September 2019Acarix publish EU growth prospectus in connection with rights issue of up to approximately SE...
Continue reading
author-avatar acarix
Corporate Action, English, IR, Issuance, MAR, News, Regulatory, Shares
November 18, 2024
25 Sep 2019

Acarix carries out a rights issue of approximately SEK 51.8 million to finance an increased market expansion

Press release  Malmö, 25 September 2019Acarix carries out a rights issue of approximately SEK 51.8 million to finance an incr...
Continue reading
author-avatar acarix
Corporate Information, English, General meeting, IR, Listing Regulation, News, Regulatory, Report of the AGM
November 18, 2024
16 Aug 2019

Announcement from Acarix’s extra general meeting

Press releaseMalmö August 5, 2019Announcement from Acarix's extra general meetingThe extra general meeting ("EGM") of Acarix AB ("...
Continue reading
author-avatar acarix
English, Interim, IR, MAR, News, Q2, Regulatory, Report
November 18, 2024
06 Aug 2019

Acarix AB (publ) publishes Interim Report, January – June 2019

Acarix AB (publ) publishes Interim Report, January – June 2019Malmö, August 6, 2019CADScor®System Included in UK guidanc...
Continue reading
author-avatar acarix
Corporate Information, English, IR, News, Other Corporate Information
November 18, 2024
05 Aug 2019

CADScor®System – Significantly more effective than current practice

Press release Malmö August 5, 2019CADScor®System – Significantly more effective than current practice Acarix AB (publ) (...
Continue reading
author-avatar acarix
Corporate Information, English, General meeting, IR, Listing Regulation, News, Notice, Regulatory
November 18, 2024
17 Jul 2019

Notice of extra general meeting in Acarix AB

Press release July 17, 2019Notice of extra general meeting in Acarix ABThe shareholders of Acarix AB, reg. no. 559009-0667, (the "Compa...
Continue reading
author-avatar acarix
Corporate Information, English, IR, News, Other Corporate Information
November 18, 2024
27 Jun 2019

Acarix CADScor®System included in NICE guidelines (UK)

Press release Malmö June 27, 2019Acarix CADScor®System included in NICE guidelines (UK) Acarix AB (publ) (ACARIX: FN Stockholm...
Continue reading
author-avatar acarix
Corporate Information, English, IR, News, Other Corporate Information
November 18, 2024
07 Jun 2019

Acarix participates on the Redeye Growth Day, Monday 10 June 2019

Acarix participates on the Redeye Growth Day, Monday 10 June 2019On Monday, June the 10th at 3.40 PM, Per Persson CEO for Acarix, will ...
Continue reading
author-avatar acarix
Corporate Information, English, General meeting, IR, Listing Regulation, News, Regulatory, Report of the AGM
November 18, 2024
20 May 2019

Announcement from Acarix’s annual general meeting

Press release Malmö, May 20, 2019Announcement from Acarix's annual general meetingThe annual general meeting ("AGM") of Acari...
Continue reading
author-avatar acarix
English, Interim, IR, MAR, News, Q1, Regulatory, Report
November 18, 2024
16 May 2019

“CADScor®System will shorten waiting lists and add value for both patients and healthcare system” Dr. Werner Kommer Facharzt für Innere Medizin und Kardiologie in Wolkersdorf, Austria

Interim Report, January – March 2019Malmö, May 16, 2019“CADScor®System will shorten waiting lists and add value fo...
Continue reading
author-avatar acarix
Annual, English, IR, MAR, News, Regulatory, Report
November 18, 2024
25 Apr 2019

Acarix publishes the annual report for 2018

Press release Malmö, April 25, 2019Acarix publishes the annual report for 2018Today, Thursday April 25, Acarix is publishing its A...
Continue reading
  • «
  • ‹
  • 17
  • 18
  • 19
  • 20
  • 21
  • ›
  • »

Acarix AB

Jungmansgatan 12
211 19 Malmö
SE
info@acarix.com

Product

Background

  • What is Coronary Artery Disease (CAD)?
  • Diagnosing CAD

About the product

  • The CADScor® System
  • How does it work

Resources

Testimonials

  • HCP stories
  • Patient stories

Support

  • Training
  • FAQ

References

  • Clinical Studies
  • Downloads (US)
  • Downloads (EU)

Investors

  • Corporate Governance
  • General Meetings
  • Financial Reports and Calendar
  • The Acarix Share
  • Rights Issue
  • Investor Presentations

Company

Who we are

  • About Acarix
  • Management
  • Join the team

Get in touch

  • Contact us
  • LinkedIn
  • Twitter

News

  • Press
  • Events
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy

Acarix, 2025. All rights reserved V6

  • Products
    • Background
    • What is Coronary Artery Disease
    • Diagnosing CAD
    • About the product
    • The Cadscor System
    • How Does it Work
  • Resources
    • Testimonial
    • HCP Stories
    • Patients Stories
    • References
    • Clinical Studies
    • Downloads (US)
    • Downloads (EU)
    • Support
    • Training
    • Faq
    • Reimbursement
    • Physician Locator
    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Right Issue
    • Previous Rights Issue
    • Investor Presentations
  • Company
    • Who we are
    • About Acarix
    • Leadership
    • Join The Team
    • Get in touch
    • Contact Us
    • Investigator Initiated Study
  • News
    • News
    • Press
    • Events
    • Socialmedia
Start typing to see products you are looking for.